March 24th: No Link to Femur Fractures Found with Bisphosphonates - in Endocrinology, Osteoporosis

Action Points  

---

• Explain to interested patients that although this study did not find a link, some case reports have suggested that atypical fractures of the femur may be more common in patients treated with bisphosphonates, the most common drugs for treating osteoporosis.
• Explain that the FDA has begun a formal safety inquiry into this potential risk, but it has emphasized that it has not yet found evidence to suggest that physicians or patients should avoid these drugs.